Bioworld Financial Watch articles from August 2006

Bioworld Financial Watch archives from August 2006

Receptor BioLogix to keep trying gastric cancer drug.(Hopeful Despite Aphton's Phase III Bust)(ture capital investment )
August 7, 2006... You could almost hear the sales pitch. "Hey, buddy, can I interest you in a late-stage cancer drug? Failed in Phase III, yeah, but we had a promising subset. Wait, don't walk away. The drug turns on the immune system--targets the gastrin...

10 biggest U.S. gainers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 7, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Cardiovascular Bio 27.54 Aeolus Pharma 24.42 Oscient Pharma 22.39 Manhattan Pharma 22.30 DURECT 22.22 Oxis Intl. ...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 7, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) BioTime -35.90 MacroChem -29.73 Matritech -27.62 Alliance Pharma -26.67 NitroMed -19.83 Genitope ...

Public financing of biotechnology: July 2006.(Statistical table)
August 7, 2006... Public Financing Of Biotechnology: July 2006 I. COMMENCED TRADING IN JULY Shares/ Shares Company Date Date Units Out (Symbol) (#) Filed ...

Other financings of public biotechnology companies.(Statistical table)
August 7, 2006... Other Financings Of Public Biotechnology Companies: July 2006 TOTAL: $459.3 Number Of Shares, Units Amount Company Type Of Or Warrants ...

Venture capital and other investments in private biotechnology companies: July 2006.(Statistical table)
August 7, 2006... Venture Capital And Other Investments In Private Biotechnology Companies: July 2006 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $276.12M Company Location Date Amt. (M) Alder Bio- Bothell,...

Milestone payments from corporate partners: July 2006.(biotechnology companies)(Statistical table)
August 7, 2006... Milestone Payments From Corporate Partners: July 2006 TOTAL: $4.5M Year to Date: $460.07M Company Partner Amt. Triggering (Symbol)(#) * (Country) (M) Event Abraxis Taiho...

Money raised by biotech in 2006: January-July.(Statistical table)(Brief article)
August 7, 2006... Money Raised By Biotech In 2006: January-July Type of financing January February March April Public offerings 542.2 486.8 922.3 574.3 Private biotechs 476.3 306.3 380.8 377.1...

BioWorld stock report for public biotechnology companies.(Statistical table)
August 7, 2006... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 7/28 8/4 Aastrom Biosci ASTM 1.2 1.22 Acadia Pharma ACAD ...

Alteon sees new life for alagebrium after merger.(Getting Up Off The Mat)
August 14, 2006... When Noah Berkowitz and HaptoGuard Inc. were approached about a possible merger with flailing Alteon Inc., they had their doubts. "We were concerned about two things," Berkowitz told BioWorld Financial Watch. "Science, and the brand of the...

10 biggest U.S. gainers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 14, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Advancis Pharma 16.22 Emisphere Techno 16.00 Palatin Technologies 15.79 Immunicon 15.38 Avax Technologies 15.38 MacroChem ...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 14, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) icagen -76.65 Cellegy Pharma -30.77 OraSure Techno -30.20 DOV Pharma -25.76 Ortec Intl. -21.21 Matritech -21.05 BioCryst Pharma -20.46...

Clinical trials update: July 2006.(Table)
August 14, 2006... Clinical Trials Update: July 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Can-Fite CF101 Adenosine-3 receptor BioPharma Ltd. agonist...

Non-U.S. clinical trials and regulatory actions: July 2006.(Table)
August 14, 2006... Non-U.S. Clinical Trials And Regulatory Actions: July 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Aspreva CellCept Mycophenolate mofetil; Pharmaceuticals ...

FDA submissions, approvals and other actions: July 2006.(Table)
August 14, 2006... FDA Submissions, Approvals And Other Actions: July 2006 Company * Product Description (Country; Symbol) AUTOIMMUNE Abbott Humira Adalimumab; fully human Laboratories ...

BioWorld stock report for public biotechnology companies.(Statistical table)
August 14, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 8/4 8/11 Aastrom Biosci ASTM 1.22 1.18 Acadia Pharma ACAD 6.19 ...

Sirna Phase I data in AMD: Lucentis challenge ahead?(Genentech's Drug Hard To Beat, But ...)
August 21, 2006... It was only Phase I data, but favorable results earlier this month with Sirna Therapeutics Inc.'s compound for age-related macular degeneration piqued the interest of Wall Street--mainly because the smaller company's work with small interfering...

10 biggest U.S. gainers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 21, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Northwest Biothera 88.89 EPIX Pharma 74.94 eXegenics 69.23 Transgenomic ...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 21, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ortec Intl. -48.94 Access Pharma -28.41 Dyadic International -24.59 Novacea Inc. ...

U.S. public offerings by underwriter: Jan. 1-July 31, 2006 *.(Statistical table)
August 21, 2006... U.S. Public Offerings By Underwriter: Jan. 1-July 31, 2006 * Underwriter Biotechnology Date Company Priced (Symbol) AG...

BioWorld stock report for public biotechnology companies.(Table)
August 21, 2006... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 8/11 8/18 Aastrom Biosci ASTM 1.18...

Anti-emetics could be next in Cephalon's oncology bid.(Despite Modafinil, FTC Woes)(Psychopharmacologic Drugs Advisory Committee's licensing of Sparlon, Antipsychotic agent)
August 28, 2006... Cephalon Inc.'s decision earlier this month--after a not-approvable letter from the FDA--to drop Sparlon (modafinil), the oral therapy for attention-deficit/hyperactivity disorder, put a 12-percent dent in the company's share value. Some...

10 biggest U.S. gainers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 28, 2006... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Viragen 46.15 eXegenics 36.36 Access Pharma 34.92 Interleukin Genetics 31.94 GenVec 29.35 AVI BioPharma ...

10 biggest U.S. losers for the week.(biotechnology companies)(Statistical table)(Brief article)
August 28, 2006... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Cyanotech -37.18 Cellegy Pharma -20.00 Northwest Biothera -17.65 Digene -11.83 Favrille -11.30 Vanda Pharma ...

U.S. public offering performance by underwriter: Jan. 1-July 31, 2006 *.(Statistical table)
August 28, 2006... U.S. Public Offering Performance By Underwriter: Jan. 1-July 31, 2006 * UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS, JAN. 1-JULY 31, 2006: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter ...

BioWorld stock report for public biotechnology companies.(Table)
August 28, 2006... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 8/18 8/25 Aastrom Biosci ASTM 1.18 1.18 Acadia Pharma ACAD ...